ARPL
AVOIDArchroma Pakistan Limited
Chemicals · 0.15% of the KSE-100
Price
Rs 89.94
Market cap
Rs 10.3bn
12-month return
-12.9%
Rank
99 of 101
Why the engine ranks it here
Archroma Pakistan Limited (ARPL) screens as one of the least attractive names in the KSE-100, ranking 99 of 101 on a composite score of 31/100.
Archroma Pakistan Limited sits in the Chemicals sector and scores best on profitability & earnings quality (52/100), weakest on valuation (34/100). At PKR 89.94 the shares trade on a P/E of 3.5x, 0.35x book, a 25.4% dividend yield. The Piotroski F-Score is 6 of 9 (strong) and the Altman Z''-Score is 7.41 (financially sound).
What it does well
ARPL reports conservative accruals at -4.7% of assets.
Profitability & earnings quality
ARPL backs its reported profit with 2.07x of operating cash.
Profitability & earnings quality
ARPL turns 4.5% of sales into free cash flow.
Profitability & earnings quality
What holds it back
ARPL is valued richly at 2.9x EV/EBITDA.
Valuation
ARPL revenue moved -11.4% over the last year.
Growth
ARPL earns only 9.9% on shareholders' money, behind its Chemicals peers.
Profitability & earnings quality
What would change this view
- → a pull-back in the share price, or earnings catching up with the current multiple
Five-pillar breakdown
Each pillar scores the company against sector peers, where 50 is the sector average.
The classic screens
Piotroski tests nine accounting facts about improvement; Altman scores the distance from financial distress.
Piotroski F-Score
6 / 9
strong · 6 of 9 tests passed
Altman Z''-Score
7.41
safe zone · safe above 5.85
Profitable on assets
ROA 4.4%
Cash generative
CFO PKR 6,054m
Returns improving
ROA 4.4% vs 0.7% a year ago
Earnings backed by cash
CFO PKR 6,054m vs profit PKR 2,924m
Deleveraging
debt/assets 0.35 vs 0.35
Liquidity improving
current ratio 1.81 vs 1.82
Margin expanding
gross margin 33.6% vs 24.8%
Assets working harder
asset turnover 0.92x vs 1.01x
No shareholder dilution
115m shares vs 115m
Altman components
Price history
Weekly closes. Beta 0.95 against the index, annualised volatility 28%, RSI 50.
Reported accounts
The last twelve quarters as filed, in PKR millions. The publication date is what the engine uses to decide when a figure became knowable.
| Quarter | Revenue | Gross profit | Operating | Net income | EPS | Filed |
|---|---|---|---|---|---|---|
| 2025 Q4 | Rs 16.4bn | Rs 6.0bn | Rs 1.9bn | Rs 993m | 8.66 | 2026-04-30 |
| 2025 Q3 | Rs 15.7bn | Rs 5.4bn | Rs 1.7bn | Rs 833m | 7.26 | 2025-11-14 |
| 2025 Q2 | Rs 16.2bn | Rs 5.8bn | Rs 1.8bn | Rs 934m | 8.14 | 2025-08-14 |
| 2025 Q1 | Rs 15.0bn | Rs 5.0bn | Rs 1.5bn | Rs 700m | 6.10 | 2025-05-15 |
| 2024 Q4 | Rs 13.8bn | Rs 4.2bn | Rs 1.3bn | Rs 457m | 3.98 | 2025-04-30 |
| 2024 Q3 | Rs 15.0bn | Rs 4.9bn | Rs 1.5bn | Rs 491m | 4.28 | 2024-11-14 |
| 2024 Q2 | Rs 17.4bn | Rs 4.5bn | Rs 1.3bn | Rs 181m | 1.58 | 2024-08-14 |
| 2024 Q1 | Rs 18.2bn | Rs 4.2bn | Rs 1.1bn | Rs 68m | 0.59 | 2024-05-15 |
| 2023 Q4 | Rs 17.8bn | Rs 3.3bn | Rs 776m | Rs -283m | -2.47 | 2024-04-29 |
| 2023 Q3 | Rs 19.3bn | Rs 3.8bn | Rs 928m | Rs -185m | -1.61 | 2023-11-14 |
| 2023 Q2 | Rs 22.8bn | Rs 5.0bn | Rs 1.3bn | Rs 142m | 1.24 | 2023-08-14 |
| 2023 Q1 | Rs 23.3bn | Rs 6.7bn | Rs 2.0bn | Rs 696m | 6.07 | 2023-05-15 |
Ranked against Chemicals
Every peer in the same sector, ordered by composite score. These are the companies whose ratios set this one's z-scores.
Scored as of 31 December 2025. Generated by an automated screen for research and educational use. Not investment advice, and not a substitute for a SECP-licensed adviser.